Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1989 Nov 1;170(5):1583–1594. doi: 10.1084/jem.170.5.1583

Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte/macrophage progenitor cells

PMCID: PMC2189508  PMID: 2478652

Abstract

Two recently identified and purified murine macrophage inflammatory proteins MIP-1 and MIP-2 were tested in vitro both alone, and in combination with purified recombinant (r) murine (mu) GM-CSF, natural (n)muCSF-1, or rhuman (hu)G-CSF, for effects on mouse marrow CFU-GM, in combination with erythropoietin for effects on mouse marrow BFU-E, and in combination with rhuGM-CSF or rhuG-CSF for effects on human marrow CFU-GM. MIP-1 and MIP-2 did not stimulate, but did enhance by up to threefold, colony formation of mouse CFU-GM co-stimulated by rmuGM-CSF and nmuCSF-1, but not by rhuG-CSF, in the absence or presence of serum. MIP-1 and MIP-2 were maximally active at concentrations greater than or equal to 100 ng/ml and the actions appeared to be initiated during the DNA synthetic portion of the cell cycle. Neither MIP-1 nor MIP-2 at up to 1 microgram/ml had any effect on mouse BFU-E, in the absence or presence of erythropoietin. Both MIP-1 and MIP-2 had direct acting effects on purified mouse CFU-GM. The cloning efficiency of 200 purified cells plated with 50 U muCSF-1 was 82% with and 43% without MIP; the cloning efficiency with 50 U rmuGM-CSF was 65% with and 35% without MIP. MIP effects were not mimicked by bacterial LPS, rhuIL-1 alpha, rhuIL-6, or rmuIL-4, and were neutralized by their respective specific antibodies. MIP-1 and MIP-2 also enhanced endogenously stimulated and rhuGM-CSF-, but not rhuG-CSF-, stimulated colony formation by human marrow CFU-GM. These results demonstrate a new role for MIP-1 and MIP-2 in vitro as myelopoietic enhancing activities for CFU-GM.

Full Text

The Full Text of this article is available as a PDF (781.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broxmeyer H. E., Cooper S., Williams D. E., Hangoc G., Gutterman J. U., Vadhan-Raj S. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1988 Aug;16(7):594–602. [PubMed] [Google Scholar]
  2. Broxmeyer H. E., Lu L., Cooper S., Schwall R. H., Mason A. J., Nikolics K. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9052–9056. doi: 10.1073/pnas.85.23.9052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Broxmeyer H. E., Lu L., Cooper S., Tushinski R., Mochizuki D., Rubin B. Y., Gillis S., Williams D. E. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. J Immunol. 1988 Dec 1;141(11):3852–3862. [PubMed] [Google Scholar]
  4. Broxmeyer H. E., Moore M. A., Ralph P. Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. Exp Hematol. 1977 Mar;5(2):87–102. [PubMed] [Google Scholar]
  5. Broxmeyer H. E., Williams D. E., Cooper S., Shadduck R. K., Gillis S., Waheed A., Urdal D. L., Bicknell D. C. Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest. 1987 Mar;79(3):721–730. doi: 10.1172/JCI112877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Broxmeyer H. E., Williams D. E. The production of myeloid blood cells and their regulation during health and disease. Crit Rev Oncol Hematol. 1988;8(3):173–226. doi: 10.1016/s1040-8428(88)80016-7. [DOI] [PubMed] [Google Scholar]
  7. Davatelis G., Tekamp-Olson P., Wolpe S. D., Hermsen K., Luedke C., Gallegos C., Coit D., Merryweather J., Cerami A. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med. 1988 Jun 1;167(6):1939–1944. doi: 10.1084/jem.167.6.1939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davatelis G., Wolpe S. D., Sherry B., Dayer J. M., Chicheportiche R., Cerami A. Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen. Science. 1989 Feb 24;243(4894 Pt 1):1066–1068. doi: 10.1126/science.2646711. [DOI] [PubMed] [Google Scholar]
  9. Ferrero D., Broxmeyer H. E., Pagliardi G. L., Venuta S., Lange B., Pessano S., Rovera G. Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4114–4118. doi: 10.1073/pnas.80.13.4114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacobsen N., Broxmeyer H. E., Grossbard E., Moore M. A. Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship. Cell Tissue Kinet. 1979 Mar;12(2):213–226. doi: 10.1111/j.1365-2184.1979.tb00127.x. [DOI] [PubMed] [Google Scholar]
  11. Lu L., Srour E. F., Warren D. J., Walker D., Graham C. D., Walker E. B., Jansen J., Broxmeyer H. E. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma. J Immunol. 1988 Jul 1;141(1):201–207. [PubMed] [Google Scholar]
  12. Lu L., Walker D., Broxmeyer H. E., Hoffman R., Hu W., Walker E. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol. 1987 Sep 15;139(6):1823–1829. [PubMed] [Google Scholar]
  13. Lu L., Walker D., Graham C. D., Waheed A., Shadduck R. K., Broxmeyer H. E. Enhancement of release from MHC class II antigen-positive monocytes of hematopoietic colony stimulating factors CSF-1 and G-CSF by recombinant human tumor necrosis factor-alpha: synergism with recombinant human interferon-gamma. Blood. 1988 Jul;72(1):34–41. [PubMed] [Google Scholar]
  14. Lu L., Welte K., Gabrilove J. L., Hangoc G., Bruno E., Hoffman R., Broxmeyer H. E. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures. Cancer Res. 1986 Sep;46(9):4357–4361. [PubMed] [Google Scholar]
  15. Ottmann O. G., Pelus L. M. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. J Immunol. 1988 Apr 15;140(8):2661–2665. [PubMed] [Google Scholar]
  16. Sherry B. A., Gelin J., Fong Y., Marano M., Wei H., Cerami A., Lowry S. F., Lundholm K. G., Moldawer L. L. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J. 1989 Jun;3(8):1956–1962. doi: 10.1096/fasebj.3.8.2721856. [DOI] [PubMed] [Google Scholar]
  17. Sherry B., Tekamp-Olson P., Gallegos C., Bauer D., Davatelis G., Wolpe S. D., Masiarz F., Coit D., Cerami A. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med. 1988 Dec 1;168(6):2251–2259. doi: 10.1084/jem.168.6.2251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sing G. K., Keller J. R., Ellingsworth L. R., Ruscetti F. W. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood. 1988 Nov;72(5):1504–1511. [PubMed] [Google Scholar]
  19. Williams D. E., Broxmeyer H. E. Interleukin-1 alpha enhances the in vitro survival of purified murine granulocyte-macrophage progenitor cells in the absence of colony-stimulating factors. Blood. 1988 Nov;72(5):1608–1615. [PubMed] [Google Scholar]
  20. Williams D. E., Cooper S., Broxmeyer H. E. Effects of hematopoietic suppressor molecules on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. Cancer Res. 1988 Mar 15;48(6):1548–1550. [PubMed] [Google Scholar]
  21. Williams D. E., Lu L., Broxmeyer H. E. Characterization of hematopoietic stem and progenitor cells. Immunol Res. 1987;6(4):294–304. doi: 10.1007/BF02935524. [DOI] [PubMed] [Google Scholar]
  22. Williams D. E., Straneva J. E., Cooper S., Shadduck R. K., Waheed A., Gillis S., Urdal D., Broxmeyer H. E. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. Exp Hematol. 1987 Nov;15(10):1007–1012. [PubMed] [Google Scholar]
  23. Williams D. E., Straneva J. E., Shen R. N., Broxmeyer H. E. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells. Exp Hematol. 1987 Mar;15(3):243–250. [PubMed] [Google Scholar]
  24. Wolpe S. D., Davatelis G., Sherry B., Beutler B., Hesse D. G., Nguyen H. T., Moldawer L. L., Nathan C. F., Lowry S. F., Cerami A. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med. 1988 Feb 1;167(2):570–581. doi: 10.1084/jem.167.2.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wolpe S. D., Sherry B., Juers D., Davatelis G., Yurt R. W., Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A. 1989 Jan;86(2):612–616. doi: 10.1073/pnas.86.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zucali J. R., Broxmeyer H. E., Gross M. A., Dinarello C. A. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. J Immunol. 1988 Feb 1;140(3):840–844. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES